Increased antibiotic use can lead, seemingly paradoxically, to more problematic infections, as the bacteria evolve to resist ...

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...

Pharmaceuticals generated fourth quarter 2024 net FUROSCIX® revenue of $12.2 million, and full year 2024 revenue of $36.3 million Cash and cash equivalents of $75.7 million as of December 31, 2024 ...

Prices of the identical generic drugs vary considerably from manufacturer to manufacturer in the country due to a lack of ...

Q4 2024 Earnings Call Transcript March 18, 2025 Operator: Greetings and welcome to the Acurx Pharmaceuticals Fourth Quarter ...

Antimicrobial resistance (AMR) is a critical global issue, contributing to increased morbidity and mortality, prolonged hospital ...

Comprehensive Urology launches its new observational study, TEM-C for Chronic Urinary Tract Infections (UTIs) for women under ...

Rosacea Therapeutics Market Analysis of Rosacea Therapeutics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, F ...

Opinion - When Lazarus Chakwera swept to power in 2020, Malawians hoped for a clean break, an end to corruption and a revival ...

According to the Dutch regulatory authority, the CMA could help reduce vulnerabilities in supply chains and improve the ...

Burn victims are being treated at hospitals throughout Europe, and officials are urging proper precautions be taken to ...